Previous 10 | Next 10 |
INOVIO Provides Update on COVID-19 Heterologous Booster Vaccine Candidate, INO-4800 PR Newswire PLYMOUTH MEETING, Pa. , Oct. 27, 2022 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to h...
INOVIO to Report Third Quarter 2022 Financial Results on November 8, 2022 PR Newswire PLYMOUTH MEETING, Pa. , Oct. 25, 2022 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat...
Summary Today I'll take another look at Inovio Pharmaceuticals. I'll explore their current pipeline, science, technology and the advantages to the DNA platform. I'll also examine four potential catalysts, which may be in the cards within the next 8 - 16 weeks. Finally, I'l...
Shares of Inovio Pharmaceuticals (NASDAQ: INO) rose 17.31% on Monday. The clinical-stage biotech company specializes in developing and commercializing DNA medicines to help treat and prevent infectious diseases, cancer, and diseases associated with HPV (human papillomavirus), the mo...
Interim phase 1/2 results for Inovio Pharmaceuticals' ( NASDAQ: INO ) INO-3107 showed a statistically significant improvement in the number of surgical interventions needed to control papilloma growth. The candidate is under investigation for HPV 6 and HPV 11-associate...
INOVIO Reports Positive Interim Phase 1/2 Results for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis PR Newswire Treatment with INO-3107 resulted in 16 of 21 (76%) participants with a reduction in number of surgical interventions compared with previ...
Summary Today, we take our first look at an outfit called Inovio Pharmaceuticals. The company is currently well funded and advancing several drug candidates including those targeting COVID-19 and HPV. An investment analysis follows in the paragraphs below. The ha...
Inovio Pharmaceuticals, Inc. (INO) H.C. Wainwright 24th Annual Global Investment Conference September 12, 2022 07:00 AM ET Company Participants Jacqueline Shea - President and CEO Conference Call Participants Brooke Katsof - H.C. Wainwright Presentation...
Developing innovative products is an excellent way for a company to become successful, and that's what Inovio Pharmaceuticals (NASDAQ: INO) is looking to do. This small-cap biotech focuses on DNA-based vaccines and treatment for cancers and infectious diseases. However, some thi...
INOVIO Reports Inducement Grants Under Inducement Plan PR Newswire PLYMOUTH MEETING, Pa. , Sept. 1, 2022 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect pe...
News, Short Squeeze, Breakout and More Instantly...
Inovio Pharmaceuticals Inc. Company Name:
INO Stock Symbol:
NASDAQ Market:
Inovio Pharmaceuticals Inc. Website:
INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024 PR Newswire PLYMOUTH MEETING, Pa. , July 25, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and ...
5G leader welcomes new Chief Product Officer, Senior Vice President Sales/Service Providers and Head of Operations Inseego Corp. (Nasdaq: INSG), a technology leader in 5G mobile and fixed wireless solutions for mobile network operators, Fortune 500 enterprises, and SMBs, today announced...
2024-07-16 13:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...